49 related articles for article (PubMed ID: 38517532)
1. Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancer.
Ueno T; Yamashita M; Yamashita N; Uomoto M; Kawamata O; Sano Y; Inokawa H; Hirayama S; Okazaki M; Toyooka S
Gen Thorac Cardiovasc Surg; 2022 Sep; 70(9):812-817. PubMed ID: 35304712
[TBL] [Abstract][Full Text] [Related]
2. Is salvage surgery for recurrent non-small-cell lung cancer after definitive non-operative therapy associated with reasonable survival?
Schreiner W; Dudek W; Sirbu H
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):682-4. PubMed ID: 26323288
[TBL] [Abstract][Full Text] [Related]
3. Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer.
Goto E; Hattori A; Fukui M; Matsunaga T; Takamochi K; Suzuki K
Surg Today; 2024 Mar; ():. PubMed ID: 38517532
[TBL] [Abstract][Full Text] [Related]
4. Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study.
Higuchi M; Inomata S; Yamaguchi H; Saito T; Suzuki H
J Cardiothorac Surg; 2023 Jul; 18(1):235. PubMed ID: 37475037
[TBL] [Abstract][Full Text] [Related]
5. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
J Cardiothorac Surg; 2016 Jan; 11():9. PubMed ID: 26781697
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study.
Suzuki S; Asakura K; Okui M; Izawa N; Sawafuji M; Sakamaki H; Shigenobu T; Tajima A; Oka N; Masai K; Kaseda K; Hishida T; Yasuda H; Fukunaga K; Asamura H
World J Surg Oncol; 2023 Sep; 21(1):290. PubMed ID: 37715273
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery.
Takenaka M; Tanaka F; Kajiyama K; Manabe T; Yoshimatsu K; Mori M; Kanayama M; Taira A; Kuwata T; Nawata A; Kuroda K
Surg Today; 2024 Mar; ():. PubMed ID: 38483630
[TBL] [Abstract][Full Text] [Related]
9. Setting a quality indicator for actual surgery time relative to scheduled surgery time in the context of increasing robotic-assisted thoracic surgery cases.
Ozeki N; Ueno H; Saeki J; Kadomatsu Y; Kato T; Nakamura S; Fukumoto K; Fukui T; Chen-Yoshikawa TF
Gen Thorac Cardiovasc Surg; 2023 Jul; 71(7):396-402. PubMed ID: 36583824
[TBL] [Abstract][Full Text] [Related]
10. Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review.
Smith A; Wali A; Montes A; Hadaki M; Harrison-Phipps K; Karapanagiotou EM; Bille A
J Surg Oncol; 2022 Feb; 125(2):290-298. PubMed ID: 34569618
[TBL] [Abstract][Full Text] [Related]
11. Bronchoplastic Procedure Versus Pneumonectomy After High-dose Radiation for Non-small Cell Lung Cancer.
Watanabe Y; Suzuki K; Hattori A; Fukui M; Matsunaga T; Oh S; Takamochi K
Ann Thorac Surg; 2021 Dec; 112(6):1832-1840. PubMed ID: 33359721
[TBL] [Abstract][Full Text] [Related]
12. A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.
Durm GA; Jabbour SK; Althouse SK; Liu Z; Sadiq AA; Zon RT; Jalal SI; Kloecker GH; Williamson MJ; Reckamp KL; Langdon RM; Kio EA; Gentzler RD; Adesunloye BA; Harb WA; Walling RV; Titzer ML; Hanna NH
Cancer; 2020 Oct; 126(19):4353-4361. PubMed ID: 32697352
[TBL] [Abstract][Full Text] [Related]
13. Salvage Lung Resections After Definitive Chemoradiotherapy: A Safe and Effective Oncologic Option.
Bograd AJ; Mann C; Gorden JA; Gilbert CR; Farivar AS; Aye RW; Louie BE; Vallières E
Ann Thorac Surg; 2020 Oct; 110(4):1123-1130. PubMed ID: 32473131
[TBL] [Abstract][Full Text] [Related]
14. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L; Mansfield AS; Szczęsna A; Havel L; Krzakowski M; Hochmair MJ; Huemer F; Losonczy G; Johnson ML; Nishio M; Reck M; Mok T; Lam S; Shames DS; Liu J; Ding B; Lopez-Chavez A; Kabbinavar F; Lin W; Sandler A; Liu SV;
N Engl J Med; 2018 Dec; 379(23):2220-2229. PubMed ID: 30280641
[TBL] [Abstract][Full Text] [Related]
15. Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors.
Bott MJ; Cools-Lartigue J; Tan KS; Dycoco J; Bains MS; Downey RJ; Huang J; Isbell JM; Molena D; Park BJ; Rusch VW; Sihag S; Jones DR; Adusumilli PS
Ann Thorac Surg; 2018 Jul; 106(1):178-183. PubMed ID: 29550207
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
